Press Release

Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
Dec 06, 2022 14:00 JST

Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities.
More info..

Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia Apr 19, 2021 09:00 JST Cielo, the world's leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to help them hire the best talent in Asia. More info..

Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER Apr 26, 2019 13:30 JST Sanofi delivered strong Q1 2019 business EPS growth of 9.4% at CER. More info..

Sanofi delivers 2018 business EPS growth of 5.1% at CER Feb 07, 2019 14:30 JST Sanofi announced the 2018 fourth-quarter and full-year results. More info..

Sanofi Delivers 2017 Business EPS in line with Guidance Feb 07, 2018 15:00 JST Sanofi Delivers 2017 Business EPS in line with Guidance More info..

Sanofi to Acquire Bioverativ for $11.6 Billion
Jan 22, 2018 14:00 JST

Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ for $105 per share in cash, representing an equity value of approximately $11.6 billion (on a fully diluted basis). The transaction was unanimously approved by both the Sanofi and Bioverativ Boards of Directors.
More info..

Sanofi: Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent(R) (alirocumab)
Oct 06, 2017 08:00 JST

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen's asserted patent claims for antibodies targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). This ruling means that Sanofi and Regeneron will continue marketing, selling and manufacturing Praluent(R) (alirocumab) injection in the U.S.
More info..

A*STAR, NUS and NUH Join Forces to Understand Immune Erosion in Elderly
Feb 13, 2014 11:30 JST

A*STAR's Singapore Immunology Network (SIgN) signed a three-year partnership with the National University of Singapore (NUS), National University Hospital (NUH) and Sanofi Pasteur to embark on a Phase IV clinical trial to understand age-related loss of immunity, known as immunosenescence, in elderly.
More info..